𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prostate cancer vs. post-biopsy hemorrhage: Diagnosis with T2- and diffusion-weighted imaging

✍ Scribed by Andrew B. Rosenkrantz; Martin Kopec; Xiangtian Kong; Jonathan Melamed; George Dakwar; James S. Babb; Bachir Taouli


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
240 KB
Volume
31
Category
Article
ISSN
1053-1807

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Purpose:

To assess the value of quantitative T2 signal intensity (SI) and apparent diffusion coefficient (ADC) to differentiate prostate cancer from post‐biopsy hemorrhage, using prostatectomy as the reference.

Materials and Methods:

Forty‐five men with prostate cancer underwent prostate magnetic resonance imaging (MRI), including axial T1‐weighted imaging (T1WI), T2WI, and single‐shot echo‐planar image (SS EPI) diffusion‐weighted imaging. Two observers measured, in consensus, normalized T2 signal intensity (SI) (nT2, relative to muscle T2 SI), ADC, and normalized ADC (nADC, relative to urine ADC) on peripheral zone (PZ) tumors, benign PZ hemorrhage, and non‐hemorrhagic benign PZ. Tumor maps from prostatectomy were used as the reference. Mixed model analysis of variance was performed to compare parameters among the three tissue classes, and Pearson's correlation coefficient was utilized to assess correlation between parameters and tumor size and Gleason score. Receiver‐operating characteristic (ROC)‐curve analysis was used to determine the performance of nT2, ADC, and nADC for diagnosis of prostate cancer.

Results:

nT2, ADC, and nADC were significantly lower in tumor compared with hemorrhagic and non‐hemorrhagic benign PZ (P < 0.0001). There was a weak but significant correlation between ADC and Gleason score (r = −0.30, P = 0.0119), and between ADC and tumor size (r = −0.40, P = 0.0027), whereas there was no correlation between nT2 and Gleason score and tumor size. The areas under the curve to distinguish tumor from benign hemorrhagic and non‐hemorrhagic PZ were 0.97, 0.96, and 0.933 for nT2, ADC, and nADC, respectively.

Conclusion:

Quantitative T2 SI and ADC/nADC values may be used to reliably distinguish prostate cancer from post‐biopsy hemorrhage. J. Magn. Reson. Imaging 2010;31:1387–1394. © 2010 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Prostate cancer screening: The clinical
✍ Akihiro Tanimoto; Jun Nakashima; Hidaka Kohno; Hiroshi Shinmoto; Sachio Kuribaya 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB 👁 1 views

## Abstract ## Purpose To evaluate the clinical value of diffusion‐weighted imaging (DWI) and dynamic MRI in combination with T2‐weighted imaging (T2W) for the detection of prostate cancer. ## Materials and Methods A total of 83 patients with elevated serum prostate specific antigen (PSA) levels

Prostate cancer detection with 3 T MRI:
✍ Kazuhiro Kitajima; Yasushi Kaji; Yoshitatsu Fukabori; Ken-ichiro Yoshida; Narufu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 1 views

## Abstract ## Purpose: To evaluate the diagnostic ability of diffusion‐weighted imaging (DWI) and dynamic contrast‐enhanced imaging (DCEI) in combination with T2‐weighted imaging (T2WI) for the detection of prostate cancer using 3 T magnetic resonance imaging (MRI) with a phased‐array body coil.

Combined diffusion-weighted and dynamic
✍ Piotr Kozlowski; Silvia D. Chang; Edward C. Jones; Kenneth W. Berean; Henry Chen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB 👁 1 views

## Abstract ## Purpose To determine whether the combination of diffusion‐weighted (DW) and dynamic contrast‐enhanced (DCE) MRI provides higher diagnostic sensitivity for prostate cancer than each technique alone. ## Materials and Methods Fourteen patients with a clinical suspicion of prostate ca

Prostate cancer: Utility of fusion of T2
✍ Andrew B. Rosenkrantz; Lorenzo Mannelli; Xiangtian Kong; Ben E. Niver; Douglas S 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

## Abstract ## Purpose: To retrospectively assess the utility of fusion of T2‐weighted images (T2WI) and high b‐value diffusion‐weighted images (DWI) for prostate cancer detection and localization. ## Materials and Methods: In this IRB‐approved HIPAA‐compliant study, 42 patients with prostate ca